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Introduction: In stroke models, Inducible Nitric Oxide Synthase (iNOS) expression initiates 
cellular toxicity due to excessive Nitric Oxide (NO) generation. Anchusa italica is a medicinal 
herb with anti-inflammatory, antioxidant and neuroprotective properties. This study evaluated 
the antioxidant activity and NOS mRNA expression of the Hydroalcoholic Extract Of Anchusa 
Italica (HEAI) in an experimental stroke model in rats. 
Methods: The stroke model was induced by bilateral occlusion of both common carotid 
arteries for 60 min. Twenty-four hours after surgery, HEAI (50 and 100 mg/kg i.p.) was 
injected daily for 10 consecutive days. mRNA expression levels of NOS subtypes and 
hippocampal Brain-Derived Neurotrophic Factor (BDNF) were studied using real-time PCR. 
Besides, hippocampal tissue plus serum concentrations of NO and Malondialdehyde (MDA) 
were measured.
Results: HEAI decreased MDA in both serum and hippocampal tissue and also reduced serum 
NO levels. Additionally, in the HEAI-treated groups, a down-regulation of iNOS mRNA 
expression, and an up-regulation of BDNF mRNA expression were observed.
Conclusion: The results indicated that the administration of HEAI even after the onset of 
ischemia protects the brain from free radical injury and inflammation via a down-regulation of 
iNOS expression inhibiting NO production and an up-regulation of BDNF mRNA.
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1. Introduction
schemic stroke is the most prevalent type 
of stroke and a leading cause of adult disabil-
ity and mortality worldwide (Bart van der 
Worp & van Gijn, 2007). Transient global 
cerebral ischemia can occur clinically, starv-
ing brain tissue of blood even temporarily to 
instigate the death of neuronal cells (Peng 
et al., 2012). Cerebral blood vessel reperfusion may also 
augment brain damage and this is known as cerebral Isch-
emia-Reperfusion (I-R) injury (Peng et al., 2012).
Multiple and complex factors, including oxidative, ex-
citotoxic, and nitrosative stress, infarct depolarization, 
inflammation, and apoptosis-like mechanisms may well 
lead to more serious damage and cell death in cerebral 
ischemic stroke (Prentice, Modi, & Wu, 2015). 
NO is a putative peripheral and central neurotransmit-
ter, which is generated by three different subtypes of 
Nitric Oxide Synthases (NOSs), namely neuronal NOS 
(nNOS), endothelial NOS (eNOS), and inducible NOS 
(iNOS) (Cui et al., 2013). Hippocampal nNOS and eNOS 
are plentiful and have an important role in learning and 
memory processes implicated in behavioral phenomena, 
such as inhibition of passive avoidance and spatial learn-
ing (Harooni, Aghdi, Sepehri, & Haeri Rohani, 2009). 
NO is involved in the formation of hippocampal short- 
and long-term memory and it has been shown that NOS 
inhibitors impair memory performance in both chicks and 
mice (Smith et al., 2016). Moreover, the NO generated 
after N-methyl-D-aspartate (NMDA) receptor stimulation 
also behaves as a retrograde messenger producing hip-
pocampal long-term potentiation (Paul & Ekambaram, 
2011). However, NO exerts all its positive learning and 
memory effects when it is generated at natural physiologi-
cal concentrations (Paul & Ekambaram, 2011).
iNOS is unregulated after I-R injury and generates ex-
cessive NO, which reacts with superoxide to form per-
oxynitrite radical causing neuronal death. Due to its high 
rate of oxidative metabolic activity, the brain is vulnerable 
to oxidative stress, intense production of Reactive Oxygen 
Species (ROS), and a high content of polyunsaturated fatty 
acids. It also has a marginal antioxidant capacity, minimal 
reparative activity, and a non-replicating nature within 
neuronal cells (Liu, Li, Zhao, Wang, Qu, & Mu, 2015). 
Enhanced levels of NO may alter its physiological neu-
romodulatory role to neurotoxic agents inducing neuronal 
inflammation and demyelination, memory impairment 
and neurodegeneration (Paul & Ekambaram, 2011).
Highlights 
● Nitric oxide synthase types include endothelial (eNOS), neuronal (nNOS), and inducible (iNOS) types.
● Both nNOS and iNOS have deleterious effects on neurons in the ischemic brain.
● BDNFis a neurotrophic factor promoting synaptic plasticity and neuronal survival.
● Anchusa italic reduced iNOS but increased BDNF mRNA expression in a stroke model.
● A. italica is an anti-inflammatory/antioxidant herb with neuroprotective properties.
Plain Language Summary 
Transient global cerebral ischemia can develop clinically. Cerebral blood vessel reperfusion may also augment brain 
damage and this is known as cerebral Ischemia-Reperfusion (I-R) injury. Nitric Oxide (NO) is a neurotransmitter in-
volved in the formation of hippocampal memory and exerts its beneficial effects when it is synthesized at physiological 
concentrations in the brain. However, enhanced levels of NO can alter its physiological neuromodulator role to a nerve-
damaging agent leading to induce inflammation. Antioxidants reduce the actions of unstable harmful oxygen-contain-
ing reactive molecules (reactive oxygen species) to protect nerve cells from I-R-induced damage in animal models. The 
medicinal plant, Anchusa italica, is a useful source of antioxidants that offers possible protection against global cerebral 
ischemia and reperfusion injury. Our findings showed that A. Italic decreases oxidative stress by down-regulating 
inducible nitric oxide synthase (iNOS) mRNA expression, and up-regulating the mRNA expression of Brain-Derived 
Neurotrophic Factor (BDNF), which boosts the survival of nerve cells during I-R.
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In contrast, eNOS confers beneficial effects during ce-
rebral ischemia (Zeng et al., 2011). Thus, eNOS can less-
en acute ischemic injury and promote recovery follow-
ing cerebral ischemia by regulating cerebral blood flow, 
maintaining cerebral homeostasis and exerting an anti-
inflammatory activity (Chen, Ivy, & Russo-Neustadt, 
2006; Chen, Cui, Zacharek, Roberts, & Chopp, 2009). 
Moreover, eNOS up-regulates the expression of Brain-
Derived Neurotrophic Factor (BDNF) (Cui et al., 2013). 
BDNF is a key neurotrophic factor, which not only pro-
motes synaptic plasticity but also neuronal survival and 
it has an integral role in certain forms of learning and 
memory. Hence, up-regulating BDNF may well decrease 
or prevent cell damage following transient forebrain isch-
emia and reduce infarct size leading to improving out-
comes (Jiang, Zuo, Wang, Lu, Yang, & Wang, 2017).
Animal models of cerebral ischemia antioxidants re-
duce ROS-mediated activity and protect neurons from I-
R-induced neural loss (Mazza, Pomponi, Janiri, Bria, & 
Mazz, 2007). In this regard, Anchusa italicah as antioxi-
dant properties decreasing the level of oxidative stress 
and also possesses free radical scavenging activity (Al-
Snafi, 2014; Al-Snafi, 2015). This herb belongs to the 
Boraginaceae family and has been advocated as a folk 
medicine in temperate Mediterranean and Tropical re-
gions. Phytochemical studies have revealed that A. Ital-
ica contains alkaloids, tannins, oil rich in vitamin E, trit-
erpenes, and polyphenols (Alsabri et al., 2012; Al-Snafi, 
2015). It exhibits several pharmacological properties, in-
cluding anticancer, antioxidant, antiviral, antimicrobial, 
hypotensive, and antidiabetic activities (Al-Snafi, 2014). 
In this context, the use of traditional medicine is wide-
spread and plants still represent a significant source of 
natural antioxidants. Consequently, the aim of this study 
was to evaluate the effect of a hydroalcoholic extract 
of A. italica, (HEAI) as a useful source of antioxidants 
on possible protection against global cerebral ischemia 
and reperfusion using an animal model. In particular, 
we focused on the involvement of the nitrosative stress 
pathway and up-regulation of the BDNF gene as the 
possible mechanism (Al-Snafi, 2014; Blondeau, Lipsky, 
Bourourou, Duncan, Gorelick, & Marini, 2015).
2. Methods
2.1. Preparation of a hydro alcoholic extract of An-
chusa italica
A. Italica was purchased from a medicinal herb sup-
plier in Shahrekord and authenticated taxonomically by 
a senior plant taxonomist in the Medical Plants Research 
Center, Shahrekord University of Medical Sciences. The 
flowers of A. italica were macerated with 70% ethanol at 
room temperature for one week. The extract was shaken, 
filtered, and evaporated in a rotary evaporator under re-
duced pressure for dryness. It was protected from light 
and stored at 4°C until tested and analyzed.
2.2. Radical scavenging assay 
The antioxidant capability of HEAI was ascertained by 
the radical scavenging capacity for DPPH according to 
our previously established method. Accordingly, the IC50 
values of HEAI were obtained for DPPH scavenging.
2.3. Total phenolic compounds in HEAI 
The concentration of total phenolic compounds in 
HEAI was evaluated by an adapted Folin–Ciocalteu 
method described earlier. 
2.4. Total flavonoids in HEAI
A colorimetric assay was employed to evaluate the total fla-
vonoid content of HEAI. Total flavonoids were expressed in 
terms of Rutin equivalent (mg/g) (Molan & Mahdy, 2014).
2.5. Animals
Male Wister rats weighing 250-300 g sourced from the 
Razi Institute (Tehran, Iran) were housed for a minimum 
of 7 days in an air-conditioned environment before test-
ing. They were maintained in controlled conditions of 
room temperature (25.0±3.0°C) and constant humidity 
(10%), on an alternating 12 h/12 h light/dark cycle and 
with ad libitum food plus water availability. The Ethics 
Committee of Shahrekord University of Medical Sci-
ences approved the study (Ethics Code: IR.SKUMS.
REC.1394.256).
2.6. Global cerebral ischemia and preparation of 
experimental material 
Animals were assigned in a random fashion to four 
groups (n=7) as follows: 1. Sham-operated; 2. I-R (con-
trol), HEAI post-treatment at doses of; 3. 50 mg/kg (AI-
50); and 4. 100 mg/kg (AI-100) administered daily for 
10 days, 24 h after I-R induction. Also, the animals in the 
sham-operated group were managed identically to con-
trols; however, they underwent surgery without global 
cerebral artery occlusion (Torki et al., 2018).
In all four groups, the rats were weighed and anesthe-
tized with an intraperitoneal (i.p.) injection of chlo-
ral hydrate (Merck, Germany) (400 mg/kg), and then 
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a midline ventral incision was made in the neck. In 
the case of induced global cerebral ischemia, the bi-
lateral carotid arteries were occluded by small artery 
clips. Sixty minutes after ischemia, reperfusion was 
performed by releasing the artery clips. In the sham-
operated group, the arteries were exposed for 60 min 
without occlusion. 
During surgery, the rectal temperature was maintained at 
37◦C by a heating pad. After reperfusion, animals were re-
turned to their separate home cages. Twenty-four hours after 
surgery, AI-50 and AI-100 groups received 50 and 100 mg/
kg HEAI for 10 days via i.p. injection, respectively. Doses 
were chosen from previously published data. The control 
and sham-operated groups received normal saline instead 
of HEAI for 10 days. Subsequently, animals were weighed 
and anesthetized with chloral hydrate. Blood was collected 
from the abdominal aorta, and then serum was separated and 
stored at -20°C. The rats were decapitated, their brains were 
removed immediately, and both hippocampi were dissected 
on ice-cold plates. One lateral hippocampus was stored at 
-70°C until the extraction of the mRNA content, whereas the 
other part was stored at -20°C until it was used in the malo-
ndialdehyde (MDA) assay.
2.7. Determination of lipid peroxide content in rat 
plasma
The formation of Thiobarbituric Acid Reactive substances 
(TBARs) is used as an index of lipid peroxidation ascertained 
as MDA. This determination was carried out according to 
the method of Mihara and Uchiyama (Uchiyama & Mihara, 
1978). Thus, 100 µl plasma or standard was mixed with 100 
µL sodium dodecyl sulfate (8.1%) and 2.5 ml of Thiobarbi-
turic Acid (TBA). The mixture was subsequently heated on 
a boiling water bath and the reaction was terminated 60 min 
later by placing the reaction tubes in ice. After centrifugation 
(4000 rpm x 10 min), the absorbance of the supernatant was 
measured at 535 nm by a flow-through spectrophotometer.
2.8. Determination of lipid peroxide content in rat 
hippocampus
Brain tissues were homogenized in ice-cold Tris-HCl 
buffer (0.05 mol/L, Ph=7.4) for 2 min at 5000 rpm. The 
homogenized solution was subsequently centrifuged at 
4300 rpm for 60 min. Then, 100 µL of the supernatant was 
mixed with 10 µL butylated hydroxytoluene (0.5 mol/L), 
200 µL sodium dodecyl sulfate (8.1%) and 1.5 mL TBA. 
This suspension was heated for 60 min in a boiling water 
bath. After cooling, 3.0 mL of butanol-pyridine was added 
to the suspension and centrifuged at 3900 rpm for 10 min. 
The organic layer was transferred to a fresh tube and its 
absorbance was measured at 535 nm using a spectropho-
tometer (Karatas, Karatepe, & Baysar, 2002).
2.9. Nitric oxide assays
Metabolites of NO in the serum were determined us-
ing the Griess reaction accompanied by the enzymatic 
reaction of nitrite and nitrate with copper-plated cadmi-
um. Thus, the serum sample was deproteinated by add-
ing ZnSO4 and NaOH solutions and activated cadmium 
granules were added to the pretreated deproteinated se-
rum. Then, Griess reagents (sulfanilamide in 5% chloric 
acid) plus N-[1-napthyl] ethylene diamine dihydrochlo-
ride) were added to the sample. Sample absorbance was 
then measured using a spectrophotometer set at 540 nm. 
Concentrations of NO were measured based on a standard 
graph derived from a range of NaNO3 concentrations.
2.10. Quantitative analysis for eNOS, iNOS, and 
BDNF mRNA in hippocampal tissue using Real-
Time-PCR
Total RNA was isolated from hippocampal tissue us-
ing total RNA extracted with TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) adopting the manufacturer’s 
recommended procedure.
Table 1. Primers used in qPCR for mRNAs
Gene NCBI Accession Number Primer Sequence
Annealing Temperature 
(°C)
PCR Product 
(bp)
iNOS NM_012611.3 F:5- AACTACGTCCTATCTCCATTCTACT-3R: 5-AACACCGCTTTCACCAAGAC-3 58 125
eNOS XM_006235872.1 F:5- AGCCCAAACACACAGAACCT-3R:5- AGCAGCACAAGAGTTACAAAATCC-3 59 145
BDNF XM_006234684.3 F:5-ACGAGACCAAGTGTAATCCC-3R:5- GCCAATTCTCTTTTTGCTATCCAT-3 57.5 137
GPDH NM_002046.7 F:5- GGTGGGGCCAAAAGGGTCAT-3R: 5- GGTTCACACCCATCACAAACAT-3 60 70
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Reverse transcription was performed on an aliquot 
containing 500 ng of total RNA. The reaction was ac-
complished on the superscript first-strand cDNA synthe-
sis system, based on the manufacturer’s recommended 
procedure (Takara, Japan). The sequences of target genes 
and the specific primers are shown in Table 1.
BDNF, iNOS, and eNOS mRNA levels were measured 
using a Rotor-Gene 6000 real-time PCR cycler (Cor-
bett, Australia). The Real-time PCR reaction was also 
performed on 1 µl of synthesized cDNA solution, 5 µl 
of SYBR Premix Ex Taq II (TliRNase H Plus) (Takara, 
Japan), and 0.2 μl of each primer. Forty amplification 
cycles consisted of denaturation at 95°C for 15 s, anneal-
ing according to Table 1 for 30 s and an extension at 
72°C for 30 s. Each sample was analyzed in triplicate. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
was utilized as a loading control to normalize target gene 
expression. Relative expression levels of the target cD-
NAs were quantified by the 2ΔΔCts method.
2.11. Statistical analysis 
Graph Pad software (San Diego, California, USA) was 
employed for data analysis. Statistical analysis of the 
data was performed employing the One-Way Analysis 
Of Variance (ANOVA) and Tukey post-hoc test to com-
pare the differences between the control group and ex-
perimental groups (P<0.05 was considered significant).
3. Results 
3.1. Standardization of HEAI
The total phenolic compound content in HEAI was 
62.2±0.3 mg gallic acid equivalent/g of dried ex-
tract. Also, the total flavonoid compound content was 
47.06±0.4 mg/g of dry matter.
3.2 Antioxidant activity of HEAI
The antioxidant activity of HEAI was evaluated using 
DPPH free radical scavenging and it possessed potent 
activity in this respect (IC50=90.5±0.3 μg/mL).
3.3. MDA content in rat serum after ischemia
MDA levels in serum are shown in Figure 1. The MDA 
serum concentration in the global cerebral ischemia group 
was higher than the sham group and the MDA levels in 
the HEAI-treated groups decreased in a dose-dependent 
manner. HEAI, at the 100 mg/kg dose, significantly re-
duced (P<0.001) the MDA level than the controls.
3.4. MDA content in rat hippocampus after ischemia
MDA levels in the hippocampus are shown in Figure 2. 
In the ischemic group, there was an elevation in MDA in 
comparison with the sham-operated group. Administra-
tion of HEAI resulted in a significant reduction (P<0.01) 
Figure 1. Serum Malondialdehyde (MDA) concentrations 
measured in treatment groups in the global cerebral artery 
occlusion stroke model
The MDA level was diminished in the hydroalcoholic ex-
tract of Anchusa italica (100 mg/kg (AI-100))-treated group 
compared with the control group.
* Values are expressed as Mean±SEM
*** P<0.001; * P<0.05; n=7
Figure 2. Hippocampal tissue Malondialdehyde (MDA) 
concentrations measured in treatment groups in the global 
cerebral artery occlusion stroke model 
The MDA levels decreased in the hydroalcoholic extract of 
Anchusa italica (100 mg/kg (AI-100))-treated group com-
pared with the control group
* Values are expressed as Mean±SEM
** P<0. 01; n=7
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in lipid peroxidation (plasma MDA levels) at the 100 
mg/kg/day dose (P<0.01) when compared with the con-
trol group. No significant difference in plasma MDA lev-
els was observed between the AI-100 and AI-50 groups.
3.5. NO content in rat serum after ischemia
NO levels in the serum are shown in Figure 3. In the 
animal control group, there was a significantly higher 
level of NO compared with the sham-operated group 
(76.26 µM/L and 35.25 µM/L, respectively). The NO 
concentrations in the HEAI-treated groups decreased in 
comparison with controls; however, there was no signifi-
cant difference (P<0.001) between NO levels in the AI-
50 and AI-100 treatment groups (25.76 µM/L and 23.59 
µM/L, respectively). 
3.6. iNOS and eNOS mRNA expression in the 
hippocampus after ischemia
Global cerebral ischemia caused a decrease in iNOS 
mRNA expression in the sham-operated animals com-
pared with the controls (P<0.001). Furthermore, HEAI 
at the doses of 50 mg/kg and 100 mg/kg both reduced 
the iNOS mRNA signal in the hippocampus compared 
with the control group (P<0.001); however, there was 
no difference in the reduction of iNOS mRNA between 
these two doses. However, the administration of HEAI 
produced an upward trend in eNOS mRNA expression 
in the hippocampus but it was not statistically significant 
and there was no difference between the effects of the two 
treatment groups (AI-50 and AI-100) (P<0.05) (Figure 4).
3.7. BDNF mRNA expression in the hippocampus 
after ischemia
Figure 3. Nitric Oxide (NO) serum concentrations measured 
in treatment groups in the global cerebral artery occlusion 
stroke model 
The levels of NO reduced in both groups treated with hy-
droalcoholic extract of Anchusa italica (50 mg/kg: AI-50 and 
100 mg/kg: AI-100) compared with the control group. 
* Values are expressed as Mean±SEM. 
*** P <0.001; *P <0.05; n=7
Figure 4. Fold-change in hippocampal tissue iNOS and eNOS mRNA expression in the global cerebral artery occlusion stroke model 
The iNOS mRNA expression level decreased in both groups treated with Hydroalcoholic Extract Of Anchusa Italica (HEAI) 
(50 mg/kg: AI-50 and 100 mg/kg: AI-100) compared with the control group.
 The eNOS mRNA expression level displayed an increasing trend in both HEAI-treated groups (AI-50 and AI-100) in compari-
son with the control group;
* Values are expressed as Mean±SEM; 
*** P<0.001; n=7
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Global cerebral ischemia resulted in significantly re-
duced BDNF mRNA hippocampal expression in the 
control group compared with sham-operated animals 
(P<0.01). HEAI at the doses of 50 and 100mg/kg both in-
creased the BDNF mRNA signal in the hippocampus than 
controls; however, no difference was observed between 
the treated groups (A-50 and AI-100; (P<0.05) (Figure 5).
4. Discussion
This is the first report regarding a protective propensity 
of HEAI against global cerebral ischemia and reperfusion 
in an animal model via inhibition of the nitrosative stress 
pathway and up-regulation of the BDNF gene. During the 
breakdown of lipid hydroperoxides, MDA is formed. It is 
an established biomarker of free radical damage in pathol-
ogies related to oxidative stress. In the first phase of our 
study, we showed that post-cerebral ischemic treatment of 
rats with HEAI, at the doses of 50 and 100mg/kg, caused a 
significant decrease in MDA levels not only in serum but 
also in hippocampal brain tissue. HEAI at the higher dose 
appeared to be more effective than the lower dose (Figure 
1). 
In agreement with these findings, there are other reports 
concerning the modulatory effect of Borago officinales 
(Boraginaceae family) on lipid peroxidation in the hip-
pocampus (Ghahremanitamadon, Shahidi, Zargooshnia, 
Nikkhah, Ranjbar, & Soleimani Asl, 2014). Besides, our 
results showed that the NO content in serum substantially 
decreased in the HEAI-treated animals compared with the 
I-R group, but this effect was not dose-dependent. Endog-
enous NO is generated by the NOS enzyme group. It has a 
wide range of physiological and pathophysiological actions 
and there are three NOS isoforms in the enzyme family, 
which are capable of producing NO (Blanco, Hernández, 
Franchelli, Ramos-Álvarez, & Peinado, 2017). NOS1 or 
neuronal NOS (nNOS) is constitutively expressed in neu-
rons in the brain. NOS2 or inducible NOS (iNOS), is not 
present under normal physiological conditions but is pro-
duced in response to immunological stimulation. NOS3 
or endothelial NOS (eNOS) has an important vasodilatory 
function and is constitutively expressed in brain endothelial 
cells (Blanco et al., 2017).
Endogenous NO released from nitrergic neurons regu-
lates the release of several monoamine neurotransmitters, 
excitatory and inhibitory amino acids, and adenosine (Prast 
& Philippu, 2001). Furthermore, NO is not only a neuro-
modulator of neurotransmitter and neuropeptide function 
presynaptically but it also promotes synaptic plasticity. In 
addition, it is implicated in both short- and long-term mem-
ory in the hippocampus. In physiological conditions, NO 
activates soluble guanylate cyclase (sGC) producing cyclic 
guanosine monophosphate (cGMP). The NO/GC pathway 
is involved in hippocampal long-term memory formation 
and it has been shown that NOS inhibitors block long-term 
potentiation (Prast & Philippu, 2001).
NO either has a protective or detrimental influence on 
ischemic brain injury, which depends on the NOS isoform 
source and the cell type (Pluta, 2005). In our study, we dis-
covered that iNOS mRNA was induced in hippocampal 
tissue following cerebral ischemia. Treatment with HEAI 
suppressed iNOS mRNA expression, which may conceiv-
ably be responsible for protective effects against ischemic 
stroke. Overexpression of NO from iNOS leads to neuro-
degeneration approved by a reduction in brain infarct vol-
ume and edema in iNOS knockout mice after transient fo-
cal ischemic injury (Hara, Huang, Panahian, Fishman, & 
Moskowitz, 1996). 
We also observed that iNOS mRNA was overexpressed 
in hippocampal tissue as a result of cerebral ischemia, but 
after HEAI treatment, this overexpression was completely 
abolished. Although NO has positive effects, if its produc-
tion becomes uncontrollably perturbed, this may be signifi-
cantly harmful as a consequence of initiating neurotoxic-
ity and apoptosis. In this context, NO and its superoxide 
combination product, peroxynitrite, have been reported 
to be conducive to the pathogenesis of neurodegenerative 
conditions (Anaeigoudari, Soukhtanloo, Reisi, Beheshti & 
Hosseini, 2016).
Figure 5. Fold-change in hippocampal tissue BDNF mRNA 
expression in the global cerebral artery occlusion stroke 
model 
The BDNF mRNA expression level increased in both hy-
droalcoholic extract of Anchusa italic-treated groups (50 
mg/kg: AI-50 and 100 mg/kg: AI-100) compared with the 
control group; 
* Values are expressed as Mean±SEM 
** P<0.01; *P <0.05; n=7
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NO has been demonstrated to incite DNA fragmenta-
tion through a mitochondrial apoptotic pathway (Wang et 
al., 2010). It can also instigate oxidative DNA damage 
and break single-stranded DNA-triggering cellular injury 
through activation of poly (ADP-ribose) polymerase, a 
nuclear enzyme that depletes essential substrates and po-
tentially contributes to neurotoxicity (Blanco et al., 2017). 
In this regard, iNOS expression may play a pathogenic 
role in the mechanisms of cerebral ischemic damage.
 Treatment with HEAI displayed a trend towards up-
regulation of eNOS mRNA expression in hippocampal 
tissue after global cerebral ischemic injury. Moreover, 
eNOS-deficient mice have been shown to exhibit a 
marked impairment of angiogenesis and increased infarct 
volume in the ischemic brain. In contrast, overexpressed 
eNOS in transgenic mice renders them resistant to stress-
induced hypotension, inflammation, and stroke (Beck & 
Plate, 2009). It is well established that global ischemia, 
caused by reduced cerebral blood flow, initiates a cas-
cade of mechanisms, including elevated levels of ROS, 
excitotoxicity, mitochondrial dysfunction and neuronal 
apoptosis (Tóthová, Kovalská, Kalenská, Tomašcová, & 
Lehotský 2018). Accordingly, eNOS has a neuroprotec-
tive role by increasing blood flow in the very early stages 
of cerebral ischemia (Hashiguchi et al., 2004). 
BDNF expression is regulated by NO generated from 
eNOS in the brain (Cao et al., 2011). This highlights the 
potentially important role of neuronally-derived eNOS 
in modulating BDNF production and the need for fur-
ther investigation of any favorable propensity of eNOS 
on neuronal survival following stroke. In this respect, 
eNOS-knockout-mice have shown a reduced expression 
of BDNF in the ischemic brain (Chen et al., 2005) and it 
has been postulated that a deficiency of eNOS associated 
with down-regulated BDNF expression, impairs neuro-
genesis after stroke. NO and BDNF appear to operate 
in a positive feedback loop promoting neurogenesis and 
eNOS may be a noteworthy target gene in new therapeu-
tic approaches for central ischemia.
Our results showed that treatment with HEAI signifi-
cantly up-regulated the expression of BDNF mRNA in 
brain tissue after ischemic injury. Furthermore, inhibition 
of NOS activity reduces the de novo synthesis of NO, 
leading to a decline in BDNF (Faraco et al., 2018) and this 
concurs with our observed down-regulated hippocampal 
BDNF mRNA expression in the I-R control group.
A. italic contains alkaloids, tannins, essential oils, trit-
erpenes and polyphenols that possess antioxidant prop-
erties, and it is regarded as one of the best sources of 
γ-linolenic acid (GLA) and α-linolenic acid (ALA) 
(Conforti et al., 2011; Al-Snafi, 2014). ALA, in particu-
lar, is known to have beneficial effects on brain ischemia 
and post-stroke depression (Blondeau et al., 2015) and 
ALA increases BDNF mRNA and protein levels dur-
ing cerebral ischemia. Additionally, recent studies have 
shown that ALA can increase neurogenesis, synaptogen-
esis, and synaptic function in the brain (Blondeau et al., 
2015), which can be a useful characteristic in stroke.
It was observed that the administration of an A. italic 
extract decreased the levels of lipid peroxidation product, 
MDA, as a marker of oxidative stress. This suggested 
that A. italica reduces oxidative stress in global cerebral 
I-R injury. We also demonstrated that HEAI down-regu-
lated iNOS mRNA expression induced an upward trend 
in eNOS mRNA, and up-regulated BDNF expression, 
which may be beneficial in the ischemic brain. 
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